362 related articles for article (PubMed ID: 18266686)
21. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
22. Clinical and demographic evaluation of Behçet disease among different paediatric age groups.
Sungur GK; Hazirolan D; Yalvac I; Ozer PA; Yuksel D; Vural ET; Duman S
Br J Ophthalmol; 2009 Jan; 93(1):83-7. PubMed ID: 18952648
[TBL] [Abstract][Full Text] [Related]
23. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
25. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
26. Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4.
Alli N; Gur G; Yalcin B; Hayran M
Am J Clin Dermatol; 2009; 10(6):411-8. PubMed ID: 19824742
[TBL] [Abstract][Full Text] [Related]
27. Uveitis associated with pediatric behçet disease in the american midwest.
Kesen MR; Goldstein DA; Tessler HH
Am J Ophthalmol; 2008 Dec; 146(6):819-27.e2. PubMed ID: 18672222
[TBL] [Abstract][Full Text] [Related]
28. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
Tognon S; Graziani G; Marcolongo R
Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
[TBL] [Abstract][Full Text] [Related]
29. [Ocular prognosis in Behçet's disease].
Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of intraocular inflammation in Hokkaido, Japan.
Kitamei H; Kitaichi N; Namba K; Kotake S; Goda C; Kitamura M; Miyazaki A; Ohno S
Acta Ophthalmol; 2009 Jun; 87(4):424-8. PubMed ID: 18652578
[TBL] [Abstract][Full Text] [Related]
31. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
Deuter CM; Zierhut M; Möhle A; Vonthein R; Stöbiger N; Kötter I
Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study.
Alpsoy E; Donmez L; Onder M; Gunasti S; Usta A; Karincaoglu Y; Kandi B; Buyukkara S; Keseroglu O; Uzun S; Tursen U; Seyhan M; Akman A
Br J Dermatol; 2007 Nov; 157(5):901-6. PubMed ID: 17711526
[TBL] [Abstract][Full Text] [Related]
33. Behçet's disease in southern Chinese patients.
Mok CC; Cheung TC; Ho CT; Lee KW; Lau CS; Wong RW
J Rheumatol; 2002 Aug; 29(8):1689-93. PubMed ID: 12180731
[TBL] [Abstract][Full Text] [Related]
34. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings.
Lannuzel A; Lamaury I; Charpentier D; Caparros-Lefebvre D
J Neurol; 2002 Apr; 249(4):410-8. PubMed ID: 11967645
[TBL] [Abstract][Full Text] [Related]
35. Uveitis in Behçet's disease.
Nussenblatt RB
Int Rev Immunol; 1997; 14(1):67-79. PubMed ID: 9203027
[TBL] [Abstract][Full Text] [Related]
36. [Venous involvement in Behcet's disease: a series of 28 cases].
Jamoussi SK; Chaaba H; Ben Dhaou B; Kochbati S; Boussema F; Cherif O; Rokbani L
Tunis Med; 2009 Dec; 87(12):829-33. PubMed ID: 20209850
[TBL] [Abstract][Full Text] [Related]
37. The increase in P-wave dispersion is associated with the duration of disease in patients with Behçet's disease.
Dogan SM; Aydin M; Gursurer M; Yildirim N; Tekin N; Altinyazar C; Onuk T; Sayin R
Int J Cardiol; 2008 Mar; 124(3):407-10. PubMed ID: 17408775
[TBL] [Abstract][Full Text] [Related]
38. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease.
Oh SH; Han EC; Lee JH; Bang D
Clin Exp Dermatol; 2009 Aug; 34(6):e208-12. PubMed ID: 19549229
[TBL] [Abstract][Full Text] [Related]
40. [Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases].
Fontes V; Machet L; Huttenberger B; Lorette G; Vaillant L
Ann Dermatol Venereol; 2002 Dec; 129(12):1365-9. PubMed ID: 12536172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
